Hc. Lin et al., HEMODYNAMIC-EFFECTS OF 8-DAY OCTREOTIDE AND PRAZOSIN ADMINISTRATION IN PORTAL HYPERTENSIVE RATS, European journal of clinical investigation, 28(8), 1998, pp. 622-628
Citations number
42
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
Background Octreotide and prazosin are both effective portal hypotensi
ve drugs in the control or prevention of variceal bleeding. The presen
t study was undertaken ro investigate the haemodynamic effects of octr
eotide and prazosin, alone or in combination, in portal hypertensive r
ats. Methods Portal hypertension was induced by partial portal vein li
gation. Portal hypertensive rats were allocated into one of the four g
roups - vehicle group (saline, 0.5 mt 12 h(-1)), octreotide group (30
mu gkg(-1) 12 h(-1)), prazosin group (0.4 mgkg(-1) 12 h(-1)), and octr
eotide (30 mu g kg(-1) 12 h(-1)) plus prazosin (0.4 mgkg(-1) 12 h(-1))
group - with eight rats in each group. Prazosin or saline was adminis
tered by gavage, whereas octreotide was administered by subcutaneous i
njection. The drug was given on the day of ligation and continued for
8 consecutive days. Systemic as well as splanchnic haemodynamic parame
ters were measured thereafter. Results Portal vein-ligated rats exhibi
ted typical hyperdynamic stare compared with sham-operated rats. The p
ortal venous pressure, portal tributary blood flow and cardiac index w
ere significantly reduced by treatment of octreotide, prazosin or octr
eotide plus prazosin in portal hypertensive rats. Hyperdynamic paramet
ers of systemic, renal and portal territory vascular resistances, and
renal as well as hepatic arterial blood flow were ameliorated by treat
ment of octreotide or octreotide plus prazosin in portal hypertensive
rats. Overall, octreotide treatment exerted more beneficial haemodynam
ic effects than prazosin treatment. The combination of octreotide and
prazosin exerted better haemodynamic effects in cardiac index but wors
e effects in systemic as well as portal territory vascular resistance
than octreotide treatment alone.